InvestorsHub Logo
icon url

Joseph_K

04/18/23 4:55 PM

#411498 RE: kevindenver #411487

I hope "we" includes Kun Jin!

"As far as next steps go, we are expecting full comprehensive results of the entire AD 2b/3 trial, which will be presented via paper or otherwise. After of course, we look forward to speaking with the FDA, EMA, TGA, and other global regulators. We believe our biomarker suite is compelling for approval."